Skip to content

Home
Technology
Products & Services
About us
News & Media
Contact

Search…

Home
Technology
Products & Services
About us
News & Media
Contact

Search…

Coronary artery disease

Coronary artery disease

Recent News

Reduced thrombogenicity of surface-treated Nitinol implants steered by altered protein adsorption
Stop the activation of the blood coagulation cascade by your medical device
Make any surface antithrombotic
Qvanteq is using MedtechVault
In-vitro thrombogenicity screening capacity

Qvanteq AG

Technoparkstr. 1, 8005 Zürich, Switzerland

+41 44 500 98 90

info@qvanteq.com

More

Meet us
Subscribe
Contact
Disclaimer

Search…

Copyright Qvanteq AG